Stanford University Cancer Institute — Palo Alto, California

Stanford University Cancer Institute is a clinical research site located in Palo Alto, California, United States 94303.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Stanford University Cancer Institute has participated in 4 clinical trials.

Therapeutic areas: Glioblastoma Multiforme, Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL).

Sponsors: NovoCure Ltd., Gamida Cell ltd, Stanford University.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University Cancer Institute?

Stanford University Cancer Institute has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University Cancer Institute conducted?

Stanford University Cancer Institute has 4 clinical trials on record. Their work covers Glioblastoma Multiforme, Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL).

Is Stanford University Cancer Institute accredited by Crixeo Health?

Stanford University Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.